Opendata, web and dolomites

ACTICAPS

Actiwhey based microencapsulation solution for sustainable food manufacturing

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ACTICAPS project word cloud

Explore the words cloud of the ACTICAPS project. It provides you a very rough idea of what is the project "ACTICAPS" about.

2022    shelf    disorders    human    nutraceuticals    release    delicate    voluntarily    validation    nutritional    70    mrsa    11    antibiotics    strategy    acticaps    licencing    overuse    customer    planning    technologies    validate    integral    validated    substances    fill    active    ratio    innovation    manufacturers    tyson    hospital    causes    uniq    market    pilot    efficiency    antibiotic    19    app    reg    fast    38m    deaths    base    valio    mcdonalds    hankkija    raisio    91    functional    incl    life    producers    generate    eacute    probiotics    foods    microencapsulation    team    threatening    sustainable    smithfield    extended    feasibility    sales    trend    coating    meat    roadmap    reduce    resistance    manuals    bioresearch    safety    diseases    3b    revenue    advantages    jobs    regulations    commercialisation    provides    countless    bon    solution    indications    create    nutrition    banning    2m    antimicrobial    business    besides    received    infections    gut    companies    actiwhey    food    meet    patented    ingredients    bacteria    free    feed    segments    tit   

Project "ACTICAPS" data sheet

The following table provides information about the project.

Coordinator
UNIQ BIORESEARCH OY 

Organization address
address: KUURINNIITYNTIE 26
city: ESPOO
postcode: 2750
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Project website http://uniqbioresearch.com/
 Total cost 1˙478˙618 €
 EC max contribution 1˙035˙033 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.3.2. (SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy)
 Code Call H2020-SMEINST-2-2015
 Funding Scheme SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-10-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIQ BIORESEARCH OY FI (ESPOO) coordinator 1˙035˙033.00

Map

 Project objective

Overuse of antibiotics in meat production causes human antimicrobial resistance, diseases and gut related disorders, leading to 1.2m life-threatening hospital infections and 19,000 deaths from MRSA-bacteria each year. The best solution is sustainable antibiotic free food production, improved food safety and nutrition value, wider use of probiotics and increased functional foods production.

Companies like Bon Appétit, Tyson Foods, Smithfield, McDonalds, etc. are voluntarily banning antibiotics treated food products. To meet this trend and EU regulations, new cost-effective technologies for processing delicate substances and active ingredients are needed in EU.

Uniq Bioresearch has developed and patented ACTIWHEY® microencapsulation technology that addresses these challenges and provides market leading nutritional efficiency; extended shelf-life, increased food safety and countless new opportunities for food, feed and nutraceuticals manufacturers.

ACTICAPS project aims to 1) reduce the microencapsulation costs by 91%; 2) achieve 70% fill-coating ratio; 3) improve controlled release and other key advantages; 4) set up pilot production for market validation and dissemination; 5) create a scale-up package, incl. process planning strategy, production manuals and licencing concept; 6) validate the innovation in 3 market segments with most potential for fast market uptake.

This project is an integral part of our long-term development roadmap. Our market uptake potential is based on 11 years of R&D and business success; established key customer base; validated patented technology, experienced team and detailed feasibility study for identifying the best business and commercialisation strategy.

We target a high growth €7.3b market and expect to generate sales revenue of €38m and create more than 50 new jobs by 2022. Besides current customer base, we have received potential order indications from market-leading feed and food producers like Hankkija, Raisio, Valio etc.

 Deliverables

List of deliverables.
Dissemination report Documents, reports 2019-05-30 17:01:51
Report on microcapsules enhanced commercial product performance Documents, reports 2019-04-30 18:24:42
Project website Websites, patent fillings, videos etc. 2019-05-30 15:02:20
Project flyer Websites, patent fillings, videos etc. 2019-05-30 15:02:25

Take a look to the deliverables list in detail:  detailed list of ACTICAPS deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ACTICAPS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ACTICAPS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.3.2.)

VIOTRAP (2015)

Elaboration of an Innovative Eco-Friendly Pest Control Method in European Agriculture

Read More  

ASEPTIC-VACBID (2016)

Energy Saving Aseptic System to Empty Concentrates out of Aseptic Bags for the Juice Production Process.

Read More  

HEALTHSTOCK (2015)

Fodder for for HEALTHier animals and improved liveSTOCK production

Read More